ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group
 

LOGIN



Please enter your username and password.


Username

Password


  
ANZMTG
 

ANZMTG 01.07 - WBRTMel Trial

This international, randomized, phase III trial will determine if the addition of whole brain radiotherapy after surgery or local stereotactic radiotherapy improves the control of melanoma metastases in the brain, neurocognitive function, survival and quality of life.
 
Study status - Closed to Recruitment.  Currently in Follow Up.
ANZ Clinical Trials Registry # - 12607000512426 
ClinicalTrials.gov identifier - NCT01503827
 
 
ANZMTG coordinator details:
Email: anzmtg0107@melanoma.org.au
Phone: +61 2 9911 7354
 
Documents (PDF downloads):


Return to Previous Page